Cognition Therapeutics Inc. (NASDAQ: CGTX) Stock Information | RedChip

Cognition Therapeutics Inc. (NASDAQ: CGTX)


$0.6197
+0.0057 ( +0.86% ) 1.8M

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Market Data


Open


$0.6197

Previous close


$0.6140

Volume


1.8M

Market cap


$25.69M

Day range


$0.5940 - $0.6340

52 week range


$0.3400 - $2.9500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 38 Dec 18, 2024
10-q Quarterly Reports 59 Nov 13, 2024
8-k 8K-related 15 Nov 13, 2024
8-k 8K-related 52 Oct 01, 2024
8-k 8K-related 13 Sep 13, 2024
8-k 8K-related 35 Aug 28, 2024
8-k 8K-related 15 Aug 08, 2024
10-q Quarterly Reports 59 Aug 08, 2024
8-k 8K-related 40 Jul 29, 2024
4 Insider transactions 1 Jun 11, 2024

Latest News